Literature DB >> 12869735

SARS in China. China's missed chance.

Martin Enserink.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12869735     DOI： 10.1126/science.301.5631.294

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  16 in total

Review 1.  What we have learnt from SARS epidemics in China.

Authors:  Nanshan Zhong; Guangqiao Zeng
Journal:  BMJ       Date:  2006-08-19

2.  Chance missed, but still there! Memoirs at the 10(th) anniversary of 2003 SARS outbreak.

Authors:  Ruiheng Xu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 3.  SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.

Authors:  Guo-ping Zhao
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

4.  Health biotechnology in China--reawakening of a giant.

Authors:  Li Zhenzhen; Zhang Jiuchun; Wen Ke; Halla Thorsteinsdóttir; Uyen Quach; Peter A Singer; Abdallah S Daar
Journal:  Nat Biotechnol       Date:  2004-12       Impact factor: 54.908

Review 5.  [Emergence of new viruses in Asia: is climate change involved?].

Authors:  C Chastel
Journal:  Med Mal Infect       Date:  2004-11       Impact factor: 2.152

6.  Sovereign Dignity, Nationalism and the Health of a Nation: A Study of China's Response in Combat of Epidemics.

Authors:  Sung-Won Yoon
Journal:  Stud Ethn Natl       Date:  2008-04-08

Review 7.  Reverse microbial etiology: A research field for predicting and preventing emerging infectious diseases caused by an unknown microorganism.

Authors:  Jianguo Xu
Journal:  J Biosaf Biosecur       Date:  2019-02-20

Review 8.  Pre-spillover prevention of emerging zoonotic diseases: what are the targets and what are the tools?

Authors:  J E Childs
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

9.  Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein.

Authors:  Zeliang Chen; Decui Pei; Lingxiao Jiang; Yajun Song; Jin Wang; Hongxia Wang; Dongsheng Zhou; Junhui Zhai; Zongmin Du; Bei Li; Maofeng Qiu; Yanping Han; Zhaobiao Guo; Ruifu Yang
Journal:  Clin Chem       Date:  2004-03-30       Impact factor: 8.327

10.  Vesivirus viremia and seroprevalence in humans.

Authors:  Alvin W Smith; Patrick L Iversen; Douglas E Skilling; David A Stein; Karin Bok; David O Matson
Journal:  J Med Virol       Date:  2006-05       Impact factor: 2.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.